Management will discuss pivotal trial plans for its drug candidate Iomab"-B and its potential as a new treatment paradigm for certain blood cancers Management will discuss pivotal trial plans for its drug candidate Iomab-B and its potential as a new treatment paradigm for certain blood cancers /PRNewswire/ -- Actinium Pharmaceuticals, Inc. , a ... (more)
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Actinium-Pharmaceuticals-to-Host-Corporate-Update-/ArticleNewsFeed/Article/detail/827172?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Actinium-Pharmaceuticals-to-Host-Corporate-Update-/ArticleNewsFeed/Article/detail/827172?ref=25
No comments:
Post a Comment